| Bayer to file for Nexavar approval for liver cancer MSN Money - FRANKFURT (Reuters) - German drugmaker Bayer plans to file this year for market approval for Nexavar to treat liver cancer after a study showed the drug significantly prolongs life for patients in the advanced stages of the disease. UPDATE 1-Bayer to file for Nexavar approval for liver cancer Bayer says Nexavar shown to extend survival for liver cancer patients |